Literature DB >> 8986833

Recombinant scrapie-like prion protein of 106 amino acids is soluble.

T Muramoto1, M Scott, F E Cohen, S B Prusiner.   

Abstract

The N terminus of the scrapie isoform of prion protein (PrPSc) can be truncated without loss of scrapie infectivity and, correspondingly, the truncation of the N terminus of the cellular isoform, PrPC, still permits conversion into PrPSc. To assess whether additional segments of the PrP molecule can be deleted, we previously removed regions of putative secondary structure in PrPC; in the present study we found that deletion of each of the four predicted helices prevented PrPSc formation, as did deletion of the stop transfer effector region and the C178A mutation. Removal of a 36-residue loop between helices 2 and 3 did not prevent formation of protease-resistant PrP; the resulting scrapie-like protein, designated PrPSc106, contained 106 residues after cleavage of an N-terminal signal peptide and a C-terminal sequence for glycolipid anchor addition. Addition of the detergent Sarkosyl to cell lysates solubilized PrPSc106, which retained resistance to digestion by proteinase K. These results suggest that all the regions of proposed secondary structure in PrP are required for PrPSc formation, as is the disulfide bond stabilizing helices 3 and 4. The discovery of PrPSc106 should facilitate structural studies of PrPSc, investigations of the mechanism of PrPSc formation, and the production of PrPSc-specific antibodies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8986833      PMCID: PMC26426          DOI: 10.1073/pnas.93.26.15457

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  57 in total

1.  Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice.

Authors:  G C Telling; T Haga; M Torchia; P Tremblay; S J DeArmond; S B Prusiner
Journal:  Genes Dev       Date:  1996-07-15       Impact factor: 11.361

2.  Circumventing tolerance to generate autologous monoclonal antibodies to the prion protein.

Authors:  R A Williamson; D Peretz; N Smorodinsky; R Bastidas; H Serban; I Mehlhorn; S J DeArmond; S B Prusiner; D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

3.  Cell-free formation of protease-resistant prion protein.

Authors:  D A Kocisko; J H Come; S A Priola; B Chesebro; G J Raymond; P T Lansbury; B Caughey
Journal:  Nature       Date:  1994-08-11       Impact factor: 49.962

4.  Structural clues to prion replication.

Authors:  F E Cohen; K M Pan; Z Huang; M Baldwin; R J Fletterick; S B Prusiner
Journal:  Science       Date:  1994-04-22       Impact factor: 47.728

5.  Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins.

Authors:  K M Pan; M Baldwin; J Nguyen; M Gasset; A Serban; D Groth; I Mehlhorn; Z Huang; R J Fletterick; F E Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

6.  Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein.

Authors:  J Safar; P P Roller; D C Gajdusek; C J Gibbs
Journal:  J Biol Chem       Date:  1993-09-25       Impact factor: 5.157

7.  Transmission dynamics and epidemiology of BSE in British cattle.

Authors:  R M Anderson; C A Donnelly; N M Ferguson; M E Woolhouse; C J Watt; H J Udy; S MaWhinney; S P Dunstan; T R Southwood; J W Wilesmith; J B Ryan; L J Hoinville; J E Hillerton; A R Austin; G A Wells
Journal:  Nature       Date:  1996-08-29       Impact factor: 49.962

8.  NMR structure of the mouse prion protein domain PrP(121-231).

Authors:  R Riek; S Hornemann; G Wider; M Billeter; R Glockshuber; K Wüthrich
Journal:  Nature       Date:  1996-07-11       Impact factor: 49.962

9.  A new inherited prion disease (PrP-P105L mutation) showing spastic paraparesis.

Authors:  T Kitamoto; N Amano; Y Terao; Y Nakazato; T Isshiki; T Mizutani; J Tateishi
Journal:  Ann Neurol       Date:  1993-12       Impact factor: 10.422

10.  Heterologous PrP molecules interfere with accumulation of protease-resistant PrP in scrapie-infected murine neuroblastoma cells.

Authors:  S A Priola; B Caughey; R E Race; B Chesebro
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

View more
  69 in total

1.  Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state.

Authors:  M Horiuchi; B Caughey
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

2.  Cultured cell sublines highly susceptible to prion infection.

Authors:  P J Bosque; S B Prusiner
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  Dominant-negative inhibition of prion formation diminished by deletion mutagenesis of the prion protein.

Authors:  L Zulianello; K Kaneko; M Scott; S Erpel; D Han; F E Cohen; S B Prusiner
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  Affinity-tagged miniprion derivatives spontaneously adopt protease-resistant conformations.

Authors:  S Supattapone; H O Nguyen; T Muramoto; F E Cohen; S J DeArmond; S B Prusiner; M Scott
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 5.  The molecular pathology of CJD: old and new variants.

Authors:  G S Jackson; J Collinge
Journal:  Mol Pathol       Date:  2001-12

6.  The role of dimerization in prion replication.

Authors:  Peter Tompa; Gábor E Tusnády; Peter Friedrich; István Simon
Journal:  Biophys J       Date:  2002-04       Impact factor: 4.033

7.  Structural studies of the scrapie prion protein by electron crystallography.

Authors:  Holger Wille; Melissa D Michelitsch; Vincent Guenebaut; Surachai Supattapone; Ana Serban; Fred E Cohen; David A Agard; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

8.  Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: structural clues for prion propagation.

Authors:  Bishwajit Kundu; Nilesh R Maiti; Eric M Jones; Krystyna A Surewicz; David L Vanik; Witold K Surewicz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-30       Impact factor: 11.205

Review 9.  Transgenesis applied to transmissible spongiform encephalopathies.

Authors:  Jean-Luc Vilotte; Hubert Laude
Journal:  Transgenic Res       Date:  2002-12       Impact factor: 2.788

10.  The region approximately between amino acids 81 and 137 of proteinase K-resistant PrPSc is critical for the infectivity of the Chandler prion strain.

Authors:  Ryo Shindoh; Chan-Lan Kim; Chang-Hyun Song; Rie Hasebe; Motohiro Horiuchi
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.